-
Je něco špatně v tomto záznamu ?
Expression of human β-N-acetylhexosaminidase B in yeast eases the search for selective inhibitors
J. Krejzová, N. Kulik, K. Slámová, V. Křen,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
- MeSH
- acetylglukosamin analogy a deriváty farmakologie MeSH
- beta-hexosaminidasa, beta řetězec antagonisté a inhibitory genetika izolace a purifikace MeSH
- exprese genu MeSH
- inhibitory enzymů farmakologie MeSH
- katalytická doména MeSH
- kinetika MeSH
- lidé MeSH
- molekulární modely MeSH
- Pichia enzymologie genetika MeSH
- rekombinantní proteiny účinky léků genetika izolace a purifikace MeSH
- thiazoly farmakologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Human lysosomal β-N-acetylhexosaminidases from the family 20 of glycoside hydrolases are dimeric enzymes catalysing the cleavage of terminal β-N-acetylglucosamine and β-N-acetylgalactosamine residues from a broad spectrum of glycoconjugates. Here, we present a facile, robust, and cost-effective extracellular expression of human β-N-acetylhexosaminidase B in Pichia pastoris KM71H strain. The prepared Hex B was purified in a single step with 33% yield obtaining 10mg of the pure enzyme per 1L of the culture media. The enzyme was used in the inhibition assays with the known mechanism-based inhibitor NAG-thiazoline and a wide variety of its derivatives in the search for specific inhibitors of the human GH20 β-N-acetylhexosaminidases over the human GH84 β-N-acetylglucosaminidase, which was expressed, purified and used in the inhibition experiments as well. Moreover, enzyme-inhibitor complexes were analysed employing computational tools in order to reveal the structural basis of the results of the inhibition assays, showing the importance of water-mediated interactions between the enzyme and respective ligands. The presented method for the heterologous expression of human Hex B is robust, it significantly reduces the costs and equipment demands in comparison to the expression in mammalian cell lines. This will enhance accessibility of this human enzyme to the broad scientific community and may speed up the research of specific inhibitors of this physiologically important glycosidase family.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17023951
- 003
- CZ-PrNML
- 005
- 20170830123253.0
- 007
- ta
- 008
- 170720s2016 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.enzmictec.2016.03.003 $2 doi
- 035 __
- $a (PubMed)27233122
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Krejzová, Jana $u Laboratory of Biotransformation, Institute of Microbiology, Czech Academy of Sciences, Vídeňská 1083, CZ 14220 Praha 4, Czech Republic; Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, Technická 5, CZ 16628 Praha 6, Czech Republic. Electronic address: janakrejza@gmail.com.
- 245 10
- $a Expression of human β-N-acetylhexosaminidase B in yeast eases the search for selective inhibitors / $c J. Krejzová, N. Kulik, K. Slámová, V. Křen,
- 520 9_
- $a Human lysosomal β-N-acetylhexosaminidases from the family 20 of glycoside hydrolases are dimeric enzymes catalysing the cleavage of terminal β-N-acetylglucosamine and β-N-acetylgalactosamine residues from a broad spectrum of glycoconjugates. Here, we present a facile, robust, and cost-effective extracellular expression of human β-N-acetylhexosaminidase B in Pichia pastoris KM71H strain. The prepared Hex B was purified in a single step with 33% yield obtaining 10mg of the pure enzyme per 1L of the culture media. The enzyme was used in the inhibition assays with the known mechanism-based inhibitor NAG-thiazoline and a wide variety of its derivatives in the search for specific inhibitors of the human GH20 β-N-acetylhexosaminidases over the human GH84 β-N-acetylglucosaminidase, which was expressed, purified and used in the inhibition experiments as well. Moreover, enzyme-inhibitor complexes were analysed employing computational tools in order to reveal the structural basis of the results of the inhibition assays, showing the importance of water-mediated interactions between the enzyme and respective ligands. The presented method for the heterologous expression of human Hex B is robust, it significantly reduces the costs and equipment demands in comparison to the expression in mammalian cell lines. This will enhance accessibility of this human enzyme to the broad scientific community and may speed up the research of specific inhibitors of this physiologically important glycosidase family.
- 650 _2
- $a acetylglukosamin $x analogy a deriváty $x farmakologie $7 D000117
- 650 _2
- $a katalytická doména $7 D020134
- 650 _2
- $a inhibitory enzymů $x farmakologie $7 D004791
- 650 _2
- $a exprese genu $7 D015870
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kinetika $7 D007700
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a Pichia $x enzymologie $x genetika $7 D010843
- 650 _2
- $a rekombinantní proteiny $x účinky léků $x genetika $x izolace a purifikace $7 D011994
- 650 _2
- $a thiazoly $x farmakologie $7 D013844
- 650 _2
- $a beta-hexosaminidasa, beta řetězec $x antagonisté a inhibitory $x genetika $x izolace a purifikace $7 D054821
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kulik, Natallia $u Department of Structure and Function of Proteins, Institute of Microbiology, Czech Academy of Sciences, Zámek 136, CZ 37333 Nové Hrady, Czech Republic. Electronic address: kulik@nh.cas.cz.
- 700 1_
- $a Slámová, Kristýna $u Laboratory of Biotransformation, Institute of Microbiology, Czech Academy of Sciences, Vídeňská 1083, CZ 14220 Praha 4, Czech Republic. Electronic address: slamova@biomed.cas.cz.
- 700 1_
- $a Křen, Vladimír $u Laboratory of Biotransformation, Institute of Microbiology, Czech Academy of Sciences, Vídeňská 1083, CZ 14220 Praha 4, Czech Republic. Electronic address: kren@biomed.cas.cz.
- 773 0_
- $w MED00001562 $t Enzyme and microbial technology $x 1879-0909 $g Roč. 89, č. - (2016), s. 1-6
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27233122 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170720 $b ABA008
- 991 __
- $a 20170830123841 $b ABA008
- 999 __
- $a ok $b bmc $g 1239632 $s 984864
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 89 $c - $d 1-6 $e 20160309 $i 1879-0909 $m Enzyme and microbial technology $n Enzyme Microb Technol $x MED00001562
- LZP __
- $a Pubmed-20170720